ArticleBreast cancer research and treatment2012

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

Laura J Esserman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.